08:00 , Dec 5, 2005 |  BC Week In Review  |  Company News

Avidis SA, Merck, sanofi-aventis deal

Merial Ltd., a JV between MRK and SAN, received rights to use Avidis' aXent, an adjuvant-free immunization technology, to develop two recombinant vaccines for infectious diseases in animals. Further terms were not disclosed. Avidis SA...
08:00 , Dec 22, 2003 |  BC Week In Review  |  Company News

Avidis board of directors update

Avidis S.A. , Clermont Ferrand, France   Business: Combinatorial chemistry/biology   Appointed: Brian Morgan, an industry consultant; David McNeilly, an industry consultant; and Thierry Plouvier, president and managing director of Chiesi SA  ...